Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Neural Regulation01:37

Neural Regulation

44.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ageing stress signalling: metastatic plasticity and metabolic vulnerability in lung cancer.

Signal transduction and targeted therapy·2026
Same author

Retraction Note: Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells.

Experimental & molecular medicine·2026
Same author

Detection of atrial fibrillation via adhesive single-lead ECG vs. Holter monitoring in embolic stroke of undetermined source: the AVANT-GARDE trial.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026
Same author

Therapeutic Effects of Fermented Soy Extract on Osteoporotic Changes in Ovariectomized Mice as a Model of Menopause.

Molecular nutrition & food research·2026
Same author

Angelic Acid Disassembles Fibrillar α-Synuclein Aggregates through β-Sheet Interface Disruption.

ACS chemical neuroscience·2026
Same author

Ethyl acetate extract of Lactococcus lactis KR-050L suppresses IL-6/STAT3 signaling in Hep3B cells and alleviates DSS-induced colitis in mice.

Journal of biotechnology·2026

Related Experiment Video

Updated: Mar 24, 2026

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils
09:32

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils

Published on: April 13, 2017

9.0K

Neuroinflammation in Synucleinopathies.

Somin Lim1, Yewon Chun1, Jun Sung Lee1

  • 1Department of Biomedical Sciences, Neuroscience Research Institute, Seoul National University College of Medicine, Seoul, 03080, Korea.

Brain Pathology (Zurich, Switzerland)
|March 5, 2016
PubMed
Summary

Neuroinflammation plays a key role in neurodegenerative diseases like Parkinson's. Understanding how alpha-synuclein aggregates trigger inflammation is crucial for developing new treatments.

Keywords:
Parkinson's diseaseeurodegenerationinflammationmicrogliasynuclein

More Related Videos

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.5K
Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.8K

Related Experiment Videos

Last Updated: Mar 24, 2026

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils
09:32

Bioluminescence Imaging of Neuroinflammation in Transgenic Mice After Peripheral Inoculation of Alpha-Synuclein Fibrils

Published on: April 13, 2017

9.0K
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
10:03

Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons

Published on: August 16, 2020

11.5K
Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay
08:33

Targeting Alpha Synuclein Aggregates in Cutaneous Peripheral Nerve Fibers by Free-floating Immunofluorescence Assay

Published on: June 25, 2019

8.8K

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • Neuroinflammation is increasingly recognized as a significant factor in neurodegenerative diseases.
  • The precise mechanisms and triggers of inflammatory responses in affected brain tissues remain largely undefined.
  • Synucleinopathies, including Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, are characterized by alpha-synuclein aggregate deposition.

Purpose of the Study:

  • To review existing literature on the role of neuroinflammation in synucleinopathies.
  • To explore the genetic, pathological, and epidemiological evidence linking neuroinflammation to these diseases.
  • To elucidate how alpha-synuclein aggregates stimulate inflammatory responses in glial cells.

Main Methods:

  • Systematic review of genetic, pathological, and epidemiological studies.
  • Analysis of research focusing on neuroinflammation in synucleinopathies.
  • Examination of the interaction between alpha-synuclein aggregates and glial cells.

Main Results:

  • Neuroinflammation is a common feature across various synucleinopathies.
  • Alpha-synuclein aggregates are identified as key triggers of inflammatory responses mediated by glial cells.
  • Evidence suggests a complex interplay between genetic predispositions, environmental factors, and neuroinflammation in disease pathogenesis.

Conclusions:

  • Clarifying the multifaceted roles of neuroinflammation in neurodegenerative disease mechanisms is essential.
  • Targeting neuroinflammatory pathways presents a promising therapeutic strategy for synucleinopathies.
  • Further research into the precise molecular triggers and cellular responses is needed for effective disease-modifying drug development.